A new trading day began on Monday, with Procept BioRobotics Corp (NASDAQ: PRCT) stock price up 32.33% from the previous day of trading, before settling in for the closing price of $68.77. PRCT’s price has ranged from $24.83 to $85.81 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 142.74% over the last five years. Meanwhile, its annual earnings per share averaged 18.62%. With a float of $48.95 million, this company’s outstanding shares have now reached $50.77 million.
The firm has a total of 626 workers. Let’s measure their productivity. In terms of profitability, gross margin is 53.27%, operating margin of -62.09%, and the pretax margin is -58.73%.
Procept BioRobotics Corp (PRCT) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of Procept BioRobotics Corp is 5.74%, while institutional ownership is 84.62%. The most recent insider transaction that took place on Oct 15 ’24, was worth 1,811,653. In this transaction EVP, CFO of this company sold 25,000 shares at a rate of $72.47, taking the stock ownership to the 96,096 shares. Before that another transaction happened on Sep 16 ’24, when Company’s EVP, CFO sold 25,000 for $82.51, making the entire transaction worth $2,062,679. This insider now owns 96,096 shares in total.
Procept BioRobotics Corp (PRCT) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 18.62% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 23.10% during the next five years compared to -23.27% drop over the previous five years of trading.
Procept BioRobotics Corp (NASDAQ: PRCT) Trading Performance Indicators
Here are Procept BioRobotics Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.07. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 23.65.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.06, a number that is poised to hit -0.36 in the next quarter and is forecasted to reach -1.45 in one year’s time.
Technical Analysis of Procept BioRobotics Corp (PRCT)
Analysing the last 5-days average volume posted by the [Procept BioRobotics Corp, PRCT], we can find that recorded value of 1.77 million was better than the volume posted last year of 0.63 million. As of the previous 9 days, the stock’s Stochastic %D was 44.29%. Additionally, its Average True Range was 4.35.
During the past 100 days, Procept BioRobotics Corp’s (PRCT) raw stochastic average was set at 99.36%, which indicates a significant increase from 99.03% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 119.64% in the past 14 days, which was higher than the 72.38% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $76.10, while its 200-day Moving Average is $61.48. Now, the first resistance to watch is $93.48. This is followed by the second major resistance level at $95.95. The third major resistance level sits at $100.67. If the price goes on to break the first support level at $86.29, it is likely to go to the next support level at $81.57. Now, if the price goes above the second support level, the third support stands at $79.10.
Procept BioRobotics Corp (NASDAQ: PRCT) Key Stats
With a market capitalization of 4.73 billion, the company has a total of 51,424K Shares Outstanding. Currently, annual sales are 136,190 K while annual income is -105,900 K. The company’s previous quarter sales were 53,350 K while its latest quarter income was -25,630 K.
